MiR-548d-3p Promotes Gastric Cancer by Targeting RSK4

Hui Liang(Chinese Academy of Agricultural Sciences), Jun Dai(Jinan University)
Cancer Management and Research
December 1, 2020
10.2147/cmar.s278691
Cited by 9

Related Papers

<p>Large Scale, Multicenter, Prospective Study of Apatinib in Advanced Gastric Cancer: A Real-World Study from China</p>
|Cancer Management and Research|2020|39
Effectiveness and safety of low‐dose apatinib in advanced gastric cancer: A real‐world study
|Cancer Medicine|2020|24
A robust diagnostic model for high-risk MASH: integrating clinical parameters and circulating biomarkers through a multi-omics approach
|Hepatology International|2025|9
Camrelizumab-based therapies for the treatment of advanced lung cancer: a prospective, open-label, multicenter, observational, real-world study
|Frontiers in Immunology|2025|2